We are looking forward to participating in the Swiss Biotech Day again on 4 and 5 May 2026. As a pharma consulting company with a Swiss presence in Riehen/Basel, we are proud to be a member of the renowned Swiss Biotech Association.
This year, we are particularly interested in the following events and panel discussions:
1) Welcome Reception
Date: Sunday, 3 May 2026
2) Swiss Biotech Association General Assembly
Date: Monday, 4 May 2026
3) Celonic, a Swiss-Based Quality CDMO
Date: Monday, 4 May 2026
Participant: Samanta Cimitan, CEO, Celonic Group
4) Topadur Pharma AG
Date: Monday, 4 May 2026
Participant: Matthias Schaefer, CEO, Topadur Pharma AG
5) The Merits and Challenges of Swiss-Japanese Partnerships
Date: Monday, 4 May 2026
Moderator: David Urech, Swiss Biotech Association
Panelists:
- Dragan Grabulowski, Araris
- Barbara Angehrn, Numab
- Marc Gitzinger, BioVersys
- Julia Schieber, Baker McKenzie
6) Innovative LNP Delivery Expands the Reach of Nucleic Acid Therapeutics
Date: Monday, 4 May 2026
Participant: Ed Yaworski, Chief Technology Officer, Genevant Sciences
7) Maximizing Healthspan: Dementia, Metabolism, Aging
Date: Monday, 4 May 2026
Participant: Antal Szalay, MD, MBA, CEO & Founder, Ultimate Medicine
8) CanVirex AG – A Platform Approach to Solid Tumor Immunotherapy
Date: Monday, 4 May 2026
Participant: Dr. Tobias Starzmann, COO, CanVirex AG
9) Transforming Esophageal Drug Delivery: A Platform Approach with EsoCap
Date: Monday, 4 May 2026
Participant: Isabelle Racamier, CEO, EsoCap AG
10) Unlock the Full Potential of Your Injectable Product
Date: Monday, 4 May 2026
Participant: Dr. Thorsten Ullrich, New Business Development Manager, Vetter
11) Santhera Pharmaceuticals (Switzerland) Ltd
Date: Monday, 4 May 2026
Participant: Shabir Hasham, CMO, Santhera Pharmaceuticals (Switzerland) Ltd
12) From Consulting to Manufacturing: A New Production Model Tailored to Innovative Products
Date: Monday, 4 May 2026
Participant: Amel Hadri, CEO and Founder, INITS
13) Clinical Trials in Europe Done Right, Operational Excellence and Smart Use of Scientific Advice
Date: Tuesday, 5 May 2026
Moderator: Ursula Türcke, Senior Director Clinical Operations, FGK
Panelists:
- Dr. Stephanie Krumholz, Founder and CEO, therainnova AG
- Martin Krauss, Founder and Managing Director, FGK
14) Samsung Biologics
Date: Tuesday, 5 May 2026
Participants: information to follow
15) FoRx Therapeutics AG
Date: Tuesday, 5 May 2026
Participants: information to follow
16) Translating Unique Human Immune Responses into Next-Generation Antibody Therapeutics
Date: Tuesday, 5 May 2026
Participant: Christoph Esslinger, CSO, Memo Therapeutics AG
17) Challenges and Pitfalls in Selecting and Developing Cell-Based Bioassays
Date: Tuesday, 5 May 2026
Moderator: Vania Santana, Sales Manager, Solvias
Panelists:
- Daniel Galbraith, Chief Scientific Officer, Solvias
- Thomas Millward, Director, Bioanalytics, Novartis
- Reginald Clayton, Dir. Field Development, Head of Biosafety & Deputy Site Head, Solvias
- Devadarssen Murdamoothoo, Director of Operations, Cell-based Bioassay, Solvias
18) Amporin – Acute Membrane Repair for Deadly Degenerative Diseases
Date: Tuesday, 5 May 2026
Participant: Kelvin Stott, Co-founder & CEO, Amporin
We look forward to exchanging ideas with international experts from the biotechnology industry.
